Prevail Therapeutics Inc. Stock
Equities
PRVL
US74140Y1010
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 18-02-28 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 18-02-28 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |